Mark R. Hurtt
Plus aucun poste en cours
Profil
Mark R.
Hurtt has been Chief Medical Officer of Alseres Pharmaceuticals, Inc. since October 2005.
Previously, he was Senior Director-Clinical Research of Neurogen Corporation, Director-Drug Development and Director-Clinical Research of Pfizer Global Research and Development and Assistant Professor of Neurology and Pathology at the University of Pittsburgh.
Dr. Hurtt received an MD degree from Jefferson Medical College
Anciens postes connus de Mark R. Hurtt
| Sociétés | Poste | Fin |
|---|---|---|
| University of Pittsburgh | Corporate Officer/Principal | - |
Neurogen Corp.
 Neurogen Corp. Pharmaceuticals: MajorHealth Technology Neurogen Corp. operated as a drug discovery and development company. The company was headquartered in Branford, CT. | Directeur Technique/Scientifique/R&D | - |
Pfizer (St. Louis)
 Pfizer (St. Louis) BiotechnologyHealth Technology Part of Pfizer Inc., Pfizer (St. Louis) is a company that provides research services in prescription medicines for humans and animals. The company is based in Chesterfield, MO. | Directeur Technique/Scientifique/R&D | - |
| ALSERES PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | - |
Formation de Mark R. Hurtt
| Sidney Kimmel Medical College | Doctorate Degree |
Expériences
Fonctions occupées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ALSERES PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Neurogen Corp.
Neurogen Corp. Pharmaceuticals: MajorHealth Technology Neurogen Corp. operated as a drug discovery and development company. The company was headquartered in Branford, CT. | Health Technology |
Pfizer (St. Louis)
Pfizer (St. Louis) BiotechnologyHealth Technology Part of Pfizer Inc., Pfizer (St. Louis) is a company that provides research services in prescription medicines for humans and animals. The company is based in Chesterfield, MO. | Health Technology |
